Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$56,158,516
+$49,721,966 QoQ
Shares Held
46,821
+569.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#519
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $367,571,362 across 18 Drug Manufacturers - General names. LLY ranks #3 (15.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
326,790 | $82,994,856 | |
| 2 | MRK |
Merck & Co., Inc.
|
608,608 | $78,206,128 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
46,821 | $56,158,516 | |
| 4 | ABBV |
AbbVie Inc.
|
164,897 | $41,494,681 | |
| 5 | NVO |
Novo Nordisk A S
|
449,006 | $21,525,347 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
363,882 | $20,966,880 | |
| 7 | PFE |
Pfizer Inc
|
811,104 | $19,531,384 | |
| 8 | AMGN |
Amgen Inc
|
50,310 | $18,218,257 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,158,516 | 46,821 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $6,436,550 | 6,998 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,336,820 | 8,688 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $17,215,569 | 22,563 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,365,873 | 3,035 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,037,519 | 2,467 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,063,556 | 2,673 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $2,183,841 | 2,465 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $2,215,464 | 2,447 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,518,577 | 1,952 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,164,091 | 1,997 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,154,829 | 2,150 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,024,252 | 2,184 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $747,281 | 2,176 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $760,581 | 2,079 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $633,766 | 1,960 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $812,196 | 2,505 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $462,487 | 1,615 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $441,123 | 1,597 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $368,293 | 1,594 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $355,067 | 1,547 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $258,662 | 1,532 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $226,174 | 1,528 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $234,613 | 1,429 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $197,676 | 1,425 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||